Amity University Bengaluru, in collaboration with the Pharmacy Council of India (PCI) is set to host a two-day international conference on “Fostering Industry-Academia Synergy for Transformative Pharma Innovations,” on March 7-8, 2025, at its state-of-the-art campus located at Devanahalli.

India’s pharmaceutical industry plays a pivotal role in global healthcare, providing affordable generic medicines essential for treating diseases such as HIV/AIDS, tuberculosis, and cancer. While India remains a prime destination for pharmaceutical investments, the industry faces the challenge of balancing affordability with the need to strengthen research and development (R&D) capabilities.

This conference will serve as a premier global platform, bringing together pharmaceutical experts, academicians, industry leaders, and researchers to foster collaboration on pharmaceutical innovations, drug research, development, and regulatory advancements.

Important highlights include keynote addresses by renowned national and international pharma luminaries, panel discussions on emerging industry-academia collaborations, scientific presentations, poster sessions, exhibitions, specialized workshops, and networking opportunities. 

Eminent pharma personalities like Dr. Montukumar M. Patel, President, PCI and Mr. Namit Joshi Chairman-Pharmexil, Ministry of Commerce & Industries, Government of India will grace the event as chief guests. The conference will also feature insights from esteemed experts such as Dr. Deependra Singh, Chairman-PERC along with Central Council PCI members Dr. M. Niranjan Babu and Dr. Akash Ved. 

The keynote speakers of the conference include captains of the industry like Dr. Ravindra Vikram Singh, Director & Head-R & D, Merck India, Dr. Kailash C Petkar, Senior Scientist, DSIR, Ministry of Science & Technology, Dr. Arun Kumar Pandey, Senior Vice President-R&D, Alkem Laboratories Ltd., Mumbai, Dr. Aljosa Bolje, Expert-(AS & T), Novartis, Slovenia, Dr. Pranab K. Patra, Head-R& D, ADAMA, Ms. Medha Pratap, Senior Director-Clinical Network, EME Morley, UK, Dr. Ravindra Rawal, Principal Scientist (CS&T Division), CSIR-NEIST, Assam, and Dr. Chew Yik Ling, Associate Professor, UCSI University, Malaysia.

“This conference offers delegates a unique platform to network, exchange groundbreaking insights, and foster innovation through strategic industry-academia collaborations,” revealed Prof. (Dr.) D Subhakar, Vice Chancellor, Amity University Bengaluru. 

"India plays a crucial role in meeting the global demand for life-saving drugs by producing a diverse range of medications that significantly impact global healthcare. In this context, the international conference hosted by Amity University Bengaluru holds immense relevance," remarked Dr. P.S. Sali, Vice President–Academics.

Prof. (Dr.) Amit Verma, Director-Research(i/c) and Organizing Secretary of the Conference, highlighted that delegates will have an exclusive opportunity to participate in a specialized workshop on computational chemistry and molecular modelling. He further disclosed that 250 research papers have been received and that the conference is expected to attract over 500 delegates from India and across the globe.